FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079726 [Registered on: 29/01/2025] Trial Registered Prospectively
Last Modified On: 25/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda
Preventive 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Ayurvedic trial for reducing the severity of acne. 
Scientific Title of Study   A Comparative study to evaluate the efficacy of Amalaki kashay and Varun kashay mukhprakshalana in reducing the severity of Yuvana pidika as a dinacharya procedure- A Randomized Control Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Swati koshatwar 
Designation  PG Scholar department of swasthavritta 
Affiliation  chaudhary brahm prakash ayurved charak sansthan khera dabar najafgarh new delhi 
Address  Room no 222 PG deptartment of Swasthavritta chaudhary brahm prakash ayurved charak sansthan khera dabar najafgarh new delhi

South West
DELHI
110073
India 
Phone  8806390851  
Fax    
Email  koshatwarswati@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jai Singh Yadav 
Designation  Assistant Professor 
Affiliation  chaudhary brahm prakash ayurved charak sansthan khera dabar najafgarh new delhi 
Address  Room no 230 PG deptartment of Swasthavritta chaudhary brahm prakash ayurved charak sansthan khera dabar najafgarh new delhi

South West
DELHI
110073
India 
Phone  7568730726  
Fax    
Email  dr_jaisinghyadav@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Jai Singh Yadav 
Designation  Assistant Professor 
Affiliation  chaudhary brahm prakash ayurved charak sansthan khera dabar najafgarh new delhi 
Address  Room no 230 PG deptartment of Swasthavritta chaudhary brahm prakash ayurved charak sansthan khera dabar najafgarh new delhi

South West
DELHI
110073
India 
Phone  7568730726  
Fax    
Email  dr_jaisinghyadav@yahoo.co.in  
 
Source of Monetary or Material Support  
Institute block, Chaudhary brahm prakash ayurved charak sansthan, khera dabar, najafgarh, south west delhi, india 110073 
 
Primary Sponsor  
Name  Chaudhary Brahm prakash ayurved charak sansthan 
Address  Chaudhary brahm prakash ayurved charak sansthan,khera dabar najafgarh new delhi india 110073 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jai Singh Yadav  Ch Brahm prakash ayurved charak sansthan  OPD room no 20 of PG department of swasthavritta ch. brahm prakash ayurved charak sansthan, khera dabar, najafgarh new delhi-110073
South West
DELHI 
7568730726

dr_jaisinghyadav@yahoo.co.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC CBPACS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L80-L99||Other disorders of the skin and subcutaneous tissue. Ayurveda Condition: YUVANAPIDAKA (MUKHADUSHIKA),  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-mukhprakshalana (Procedure Reference: sushrut samhita, Procedure details: kashaya of amalaki is made according to sharangdhar samhita then applied over face twice a day)
(1) Medicine Name: amalaki, Reference: sushrut samhita, Route: Topical, Dosage Form: Kwatha/Kashaya, Dose: 40(ml), Frequency: bd, Duration: 30 Days
2Comparator ArmProcedure-mukhprakshalana (Procedure Reference: sushrut samhita, Procedure details: kashaya of varuna is made according to sharandhar samhita and applied over face for twice a day.)
(1) Medicine Name: varuna, Reference: tripathi E. Vaidyaratnum, Route: Topical, Dosage Form: Kwatha/Kashaya, Dose: 40(ml), Frequency: bd, Duration: 30 Days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  30.00 Year(s)
Gender  Both 
Details  patients having symptoms of acne vulgaris like multiple papular eruptions on face associated with pain, inflammation, discharge and discolouration and with associated symptoms like itching, blackheads whiteheads papules pustules redness around skin eruptions 
 
ExclusionCriteria 
Details  1.history of hypersensitivity 2.patient having skin problems like scabies, eczema, fungal infections 3. patient on corticosteroids and antitubercular drugs 4. patient having acne due to acromegaly, androgen secreting tumours  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Decreased grade of severity according to the CASS scale (comprehensive acne severity scale)  0,15th,30th,45th day 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in subjective parameters of acne vulgaris.  0,15th,30th,45th day 
 
Target Sample Size   Total Sample Size="88"
Sample Size from India="88" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study is randomized control trial to compare the effect of amalaki kashay mukhprakshalana and varun kashay mukhprakshalana in reducing the severity of yuvana pidika. In one group amalaki kashay is given for mukhprakshalana in two settings daily for 30 days with follow up on 15th, 30th, 45th day. in another group varun kashay mukhprashalana is given in two settings daily for 30 days with follow up on 15th, 30th, 45th day.The trial will be conducted in Ch. brahm prakash ayurved charak sansthan with outcome mukhprakshalana with amalaki kashay show better efficacy than varun kashay in reducing the severity of yuvana pidika in improving CASS score and other associated symptoms.  
Close